Información de la revista
Vol. 104. Núm. 4.
Páginas 361 (Mayo 2013)
Vol. 104. Núm. 4.
Páginas 361 (Mayo 2013)
Letter to the Editor
Acceso a texto completo
Response to: “Orofacial Granulomatosis in Spain”
Réplica a: «Granulomatosis orofacial en España»
Visitas
...
M.L. Martínez Martínez��
Autor para correspondencia
mlmartinezm@sescam.jccm.es

Corresponding author.
, J.M. Azaña Defez
Servicio de Dermatología, Complejo Hospitalario Universitario de Albacete, Albacete, España
Información del artículo
Texto completo
Bibliografía
Descargar PDF
Estadísticas
Texto completo
To the Editor:

We are grateful for Dr Marcoval's comments concerning our recently published article in Actas Dermosifiliográficas: “Granulomatous Cheilitis: A Report of 6 Cases and a Review of the Literature.”1

As in the series published by Marcoval et al.,2 and with the limitations noted (the small number of patients in our series and the retrospective nature of the study), none of our patients had Crohn disease. In our opinion, rather than raising doubts about our medical practice, such a finding can probably be explained, as Marcoval suggests, by the epidemiologic variation of this disease across the different populations that have been studied.3 In both Europe and the United States, the incidence and prevalence of this disease is higher in the north, and this north-south variation is present even within the same country.4 A 1996 study found that the incidence of Crohn disease was 80% higher in northern Europe than in Mediterranean countries.5 Moreover, the risk of developing inflammatory bowel disease in the United States is lowest in the population of Hispanic origin.3 We agree with Marcoval on the question of colonoscopies in patients with granulomatous cheilitis and reiterate that this procedure is not justified in patients who have no signs or symptoms suggestive of inflammatory bowel disease.

Despite the limitations that our two simultaneously published studies1,2 may present, it is interesting to observe that we reached very similar conclusions. However, a larger sample size would serve to confirm the conclusions, and a multicenter study would be needed to achieve such a sample.

References
[1]
M.L. Martínez Martínez, J.M. Azaña-Defez, L.J. Pérez-García, M.T. López-Villaescusa, M. Rodríguez Vázquez, C. Faura Berruga.
Queilitis granulomatosa. Presentación de 6 casos y revisión de la literatura.
Actas Dermosifiliogr, 103 (2012), pp. 718-724
[2]
J. Marcoval, M. Viñas, X. Bordas, A. Jucglà, O. Servitje.
Orofacial granulomatosis: clinical study of 20 patients.
Oral Surg Oral Med Oral Pathol Oral Radiol, 113 (2012), pp. e12-e17
[3]
O. Hovde, B.A. Moum.
Epidemiology and clinical course of Crohn's disease; results from observacional studies.
World J Gastroenterol, 18 (2012), pp. 1723-1731
[4]
V. Nerich, E. Monnet, A. Etienne, S. Louafi, C. Ramée, S. Rican, et al.
Geographical variations of inflammatory bowel disease in France: a study based on national health insurance data.
Inflamm Bowel Dis, 12 (2006), pp. 218-226
[5]
S. Shivananda, J. Lennard-Jones, R. Logan, N. Fear, A. Price, R. Carpenter, et al.
Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the european Collaborative Study on Inflammatory Bowel Disease (EC-IBD).
Gut, 39 (1996), pp. 690-697

Please cite this article as: Martínez Martínez ML, Azaña Defez JM. Réplica a: «Granulomatosis orofacial en España». Actas Dermosifiliogr. 2014;104:361.

Copyright © 2012. Elsevier España, S.L. and AEDV
Idiomas
Actas Dermo-Sifiliográficas

Suscríbase a la newsletter

Opciones de artículo
Herramientas
es

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?